| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |